A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05021120 |
|
Recruitment Status :
Recruiting
First Posted : August 25, 2021
Last Update Posted : January 9, 2023
|
Sponsor:
Akesobio Australia Pty Ltd
Information provided by (Responsible Party):
Akeso ( Akesobio Australia Pty Ltd )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | January 10, 2025 |
| Estimated Study Completion Date : | April 7, 2025 |